Endogenous angiogenesis inhibitors act as tumor suppressor proteins.
内源性血管生成抑制剂可作为一种抑癌蛋白。
Angiogenesis inhibitors prevent the tumors from creating blood vessels.
血管生成抑制剂可以阻止肿瘤生成血管。
Several types of angiogenesis inhibitors reveal a biphasic, U-shaped curve of efficacy.
一些类型的血管生成抑制剂表现出一种双向性，成u行曲线的效能。
Objective to investigate the effects of tumor angiogenesis inhibitors SU6668 on healing of colonic anastomoses in the dog.
目的研究肿瘤血管生成抑制剂SU6668对结肠癌术后肠吻合口愈合的影响。
As potential anti tumor agents, a list of angiogenesis inhibitors are currently undergoing clinical and pre clinical study.
一批新生血管抑制物正处于临床或临床前试验的研究阶段。
Two angiogenesis inhibitors have been developed that have a broad spectrum of anticancer activity, yet virtually no side effects.
目前，已有两种具有广谱抗肿瘤活性且无明显副作用的血管生成抑制剂面世。
Multiple angiogenesis inhibitors have been therapeutically validated in preclinical cancer models, and several in clinical trials.
多种血管生成抑制剂已经在临床前期癌症模型中证实有效，并有几种临床证实有效。
In addition, several angiogenesis inhibitors have been approved by the FDA as therapy for cancer or intraocular neovascular disorders.
此外，一些血管生成抑制剂已被FDA批准作为治疗癌症或眼内新生血管性疾病。
Recently, many endogenous angiogenesis inhibitors have been discovered, some of them are currently in various stages of clinical trials.
近年来，研究发现了多种内源性血管生成抑制因子，其中一些已进入了临床试验阶段。
This review focused on the structure, function, and mechanism of endogenous angiogenesis inhibitors, and their potential in treating tumor.
本文对内源性血管生成抑制因子的结构、功能、作用机制及其在肿瘤治疗中的应用进行综述。
Tumor angiogenesis, resulting from the imbalance of angiogenic cytokines and angiogenesis inhibitors, is crucial for tumor growth and metastasis.
肿瘤血管生成是肿瘤生长转移的关键步骤，是促血管生成因子和抑制因子作用失衡的结果。
And, most famously, the class of compounds known as angiogenesis inhibitors keep tumors from building new blood vessels to supply themselves with food and oxygen.
最有名的是一类叫血管生成抑制剂的化合物，它们能阻止肿瘤生成新的血管来给自身输送营养和氧气。
Conclusion: The molecular mechanism of tumor angiogenesis needs to be studied truly and completely. Research on tumor angiogenesis inhibitors provides a new an...
结论：肿瘤血管生成的分子机制还需要真正全面了解，而肿瘤血管生成抑制剂的研制为肿瘤治疗提供了新的更为广阔的前景。
As the features of angiogenesis inhibitors are of low toxicity and have less acquired resistance, it comes to a new strategy to suppress tumor growth by restraining angiogenesis.
由于抗血管生成药物具有毒性低、不易产生获得性耐药的特点。因此，通过抑制血管生成来抑制肿瘤生长成为目前肿瘤治疗的策略之一。
Conclusion: The molecular mechanism of tumor angiogenesis needs to be studied truly and completely. Research on tumor angiogenesis inhibitors provides a new and wide prospect for treating tumor.
结论：肿瘤血管生成的分子机制还需要真正全面了解，而肿瘤血管生成抑制剂的研制为肿瘤治疗提供了新的更为广阔的前景。
She says that this could explain why cancer drugs aimed at choking off a tumor's blood supply by blocking growth signals, known as angiogenesis inhibitors, usually stop working within about 6 months.
她说这也就可以解释为什么试图通过血管生成抑制因子来阻断血管生长信号而阻断肿瘤血液供应的药物通常在六周内失去作用。
Present results also suggested that zebrafish as a quality model for study on vasculogenesis and angiogenesis during embryonic development and screening for angiogenic enhancer or inhibitors.
斑马鱼是研究胚胎发育早期微血管发生和血管发生的极佳动物模型，可用于促血管发生或抑制血管发生药物筛选。
This article mainly reviewed the structures, functional characteristics, relationship between VEGF and its inhibitors and tumor angiogenesis.
作者对VEGF家族成员及其受体的理化特征、VEGF与肿瘤的关系、VEGF抑制剂的研制作一综述。
Angiogenesis is the key step in tumors proliferation and metastasis, which depends on the net balance between endogenous stimulators and inhibitors.
血管形成是实体肿瘤增殖和转移的关键步骤，这一过程依赖于内源性刺激因子和抑制因子之间的平衡。
Angiogenesis is the key step in tumors proliferation and metastasis, which depends on the net balance between endogenous stimulators and inhibitors.
血管形成是实体肿瘤增殖和转移的关键步骤，这一过程依赖于内源性刺激因子和抑制因子之间的平衡。
应用推荐